Effect of Platelet Inhibition by Cangrelor Among Obese Patients Undergoing Coronary Stenting: Insights From CHAMPION
Sign Up to like & getrecommendations! Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.121.011069
Abstract: Background: In randomized trials, cangrelor reduced periprocedural ischemic events related to percutaneous coronary intervention without increasing GUSTO severe bleeding. However, some antiplatelet agents have shown a differential treatment effect by body mass index (BMI). Methods:… read more here.
Keywords: cangrelor; platelet inhibition; cangrelor versus; obese patients ... See more keywords